1. Home
  2. CNTB vs STHO Comparison

CNTB vs STHO Comparison

Compare CNTB & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • STHO
  • Stock Information
  • Founded
  • CNTB 2012
  • STHO N/A
  • Country
  • CNTB United States
  • STHO United States
  • Employees
  • CNTB N/A
  • STHO N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • STHO Real Estate
  • Sector
  • CNTB Health Care
  • STHO Real Estate
  • Exchange
  • CNTB Nasdaq
  • STHO Nasdaq
  • Market Cap
  • CNTB 94.2M
  • STHO 112.7M
  • IPO Year
  • CNTB 2021
  • STHO N/A
  • Fundamental
  • Price
  • CNTB $1.71
  • STHO $7.32
  • Analyst Decision
  • CNTB Strong Buy
  • STHO
  • Analyst Count
  • CNTB 3
  • STHO 0
  • Target Price
  • CNTB $8.33
  • STHO N/A
  • AVG Volume (30 Days)
  • CNTB 78.5K
  • STHO 41.1K
  • Earning Date
  • CNTB 11-30-2025
  • STHO 11-05-2025
  • Dividend Yield
  • CNTB N/A
  • STHO N/A
  • EPS Growth
  • CNTB N/A
  • STHO N/A
  • EPS
  • CNTB N/A
  • STHO N/A
  • Revenue
  • CNTB $1,965,000.00
  • STHO $113,989,000.00
  • Revenue This Year
  • CNTB N/A
  • STHO N/A
  • Revenue Next Year
  • CNTB $453,067.90
  • STHO N/A
  • P/E Ratio
  • CNTB N/A
  • STHO N/A
  • Revenue Growth
  • CNTB N/A
  • STHO N/A
  • 52 Week Low
  • CNTB $1.23
  • STHO $6.06
  • 52 Week High
  • CNTB $2.20
  • STHO $12.95
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 51.92
  • STHO 33.67
  • Support Level
  • CNTB $1.46
  • STHO $7.53
  • Resistance Level
  • CNTB $1.72
  • STHO $8.00
  • Average True Range (ATR)
  • CNTB 0.14
  • STHO 0.27
  • MACD
  • CNTB -0.01
  • STHO -0.01
  • Stochastic Oscillator
  • CNTB 56.82
  • STHO 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

Share on Social Networks: